Perrigo Company plc $PRGO Stock Holdings Boosted by Legal & General Group Plc

Legal & General Group Plc lifted its position in shares of Perrigo Company plc (NYSE:PRGO) by 34.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 361,383 shares of the company’s stock after acquiring an additional 91,622 shares during the period. Legal & General Group Plc’s holdings in Perrigo were worth $5,030,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of PRGO. Amundi grew its position in shares of Perrigo by 11.7% during the first quarter. Amundi now owns 5,292 shares of the company’s stock worth $148,000 after acquiring an additional 556 shares during the last quarter. Goldman Sachs Group Inc. grew its position in shares of Perrigo by 126.6% during the first quarter. Goldman Sachs Group Inc. now owns 1,159,768 shares of the company’s stock worth $32,520,000 after acquiring an additional 647,982 shares during the last quarter. United Services Automobile Association bought a new position in shares of Perrigo during the first quarter worth about $250,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Perrigo by 6.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 513,112 shares of the company’s stock worth $14,388,000 after acquiring an additional 32,151 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its position in shares of Perrigo by 439.1% during the first quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock worth $27,000 after acquiring an additional 786 shares during the last quarter. Institutional investors own 95.91% of the company’s stock.

Perrigo Price Performance

Shares of NYSE PRGO opened at $10.85 on Monday. Perrigo Company plc has a twelve month low of $9.23 and a twelve month high of $28.43. The company has a current ratio of 2.72, a quick ratio of 1.59 and a debt-to-equity ratio of 1.45. The company has a market capitalization of $1.50 billion, a price-to-earnings ratio of -0.83, a PEG ratio of 1.28 and a beta of 0.51. The firm has a 50-day moving average of $11.07 and a two-hundred day moving average of $12.51.

Perrigo (NYSE:PRGO) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.04. Perrigo had a negative net margin of 43.50% and a positive return on equity of 9.96%. The company had revenue of $841.80 million during the quarter, compared to the consensus estimate of $1.04 billion. During the same period in the prior year, the company earned $0.60 EPS. Perrigo’s revenue was down 7.2% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, analysts expect that Perrigo Company plc will post 2.12 earnings per share for the current fiscal year.

Perrigo Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Friday, May 29th will be issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 10.7%. The ex-dividend date of this dividend is Friday, May 29th. Perrigo’s dividend payout ratio is presently -8.85%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Weiss Ratings downgraded shares of Perrigo from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 28th. Zacks Research raised shares of Perrigo from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Jefferies Financial Group reaffirmed a “hold” rating on shares of Perrigo in a report on Thursday, February 26th. Finally, Canaccord Genuity Group reduced their price objective on shares of Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a report on Friday, February 27th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Perrigo currently has a consensus rating of “Hold” and a consensus target price of $19.33.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.